PMDA
- Application: Tabrecta
- Local brand name: Tabrecta
- Status: approved
🇯🇵 Tabrecta in Japan
Tabrecta (CAPMATINIB) regulatory status in Japan.
Marketing authorisation
Tabrecta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Tabrecta approved in Japan?
Yes. PMDA has authorised it.
Who is the marketing authorisation holder for Tabrecta in Japan?
Novartis Pharm is the originator. The local marketing authorisation holder may differ — check the official source linked above.